Abstract:Published results suggests that high adiponectin level may decrease the risk of breast cancer. However, available evidence on breast cancer is conflicting. Therefore a meta-analysis was performed to assess the association between blood adiponectin and breast cancer risk. PubMed database, Web of Science, Elsevier Science, Springer Link and bibliographies of retrieved articles were searched for epidemiological studies published up to March 2013. Meta-analysis was performed on the combined effect values (OR) as well as standardized mean difference (SMD) including 17 studies. Fixed or random effect pooled measure was selected on the basis of homogeneity test among studies. The publication bias was assessed by the Egger's regression asymmetry test and Begg's rank correlation test with Begg's funnel plot. Subgroup analyses and sensitivity analysis were also performed. A total of 13 studies involving 3578 breast cancer cases and 4363 controls contributed to the OR analysis. The high adiponectin level did not significantly affect breast cancer risk (OR=0.902, 95% CI=0.773-1.053). After excluding articles that were the key contributors to between-study heterogeneity, the OR of high adiponectin level was associated with decreased breast cancer risk (OR=0.838, 95% CI=0.744-0.943). There was a significantly association between high adiponectin level and postmenopausal breast cancer women (OR=0.752, 95% CI=0.604-0.936); and it was not associated with premenopausal breast cancer women (OR=0.895, 95% CI=0.638-1.256). The result of pooled measure on SMD was that the high adiponectin level was associated with decreased breast cancer risk (SMD= -0.348, 95% CI= -0.533-0.614) after excluding articles which were the key contributors to between-study heterogeneity. Our findings indicate that high adiponectin level might decrease the risk of postmenopausal breast cancer. More randomized clinical trials and observational studies are needed to confirm this association with underlying biological mechanisms in the future.

Advances in Research of Association Between Adiponectin and Coronary Atherosclerosis

Effect of adiponectin on obesity-linked diseases

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

Adiponectin Levels Are Associated with the Number and Activity of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease

The Function of Adiponectin in the Initiation and Progression of Coronary Heart Disease

Research Progress of Adipokines Gene Polymorphism and Atherosclerosis of Coronary Artery

Recent Advances on Adiponectin Receptor

Mechanism of Action and Risk Prediction of Adiponectin in Cardiovascular Diseases

[The Relationship Between Adiponectin and Coronary Heart Disease Metabolic Risk Factors in Non-Diabetic Male Patients].

New advances of adiponectin in regulating obesity and related metabolic syndromes

Advances in Research into Relationship Between Adipose Tissue and Chronic Heart Failure

Research progress of adiponectin and its receptors

[Research progress in regulation of adiponectin receptors expression].

Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives

Adiponectin and Adiponectin Receptors in Atherosclerosis

The Role of Adiponectin in Breast Cancer: A Meta-Analysis

Relationship between serum adiponectin and coronary heart disease

[Association Between Plasma Adiponectin Levels and Coronary Lesion Complexity].

Adiponectin, lipids and atherosclerosis

Association between adiponectin and coronary artery disease in postmenopausal women

Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders